UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 38

Sortiert nach

Letter to the editor

Toxicological sciences, 2023-01, Vol.191 (1), p.192-192

2023

Volltextzugriff (PDF)

Letter to the editor

Toxicological sciences, 2023-01, Vol.191 (1), p.192-192

2023

Volltextzugriff (PDF)

Threshold of Toxicological Concern: Extending the chemical space by inclusion of a highly curated dataset for organosilicon compounds

Regulatory toxicology and pharmacology, 2021-12, Vol.127, p.105074-105074, Article 105074

2021

Volltextzugriff (PDF)

Framework for Identifying Chemicals with Structural Features Associated with the Potential to Act as Developmental or Reproductive Toxicants

Chemical research in toxicology, 2013-12, Vol.26 (12), p.1840-1861

2013

Volltextzugriff (PDF)

Correlation of chemical structure with reproductive and developmental toxicity as it relates to the use of the threshold of toxicological concern

Regulatory toxicology and pharmacology, 2012-02, Vol.62 (1), p.160-182

2012

Volltextzugriff (PDF)

Carboxylic Acid-Terminated Hyperbranched Polybenzoxazole and Its Polyarm-Star Block Copolymers

Macromolecules, 2009-03, Vol.42 (5), p.1541-1553

2009

Volltextzugriff (PDF)

Development of new pyrrolopyrimidine-based inhibitors of Janus kinase 3 (JAK3)

Bioorganic & medicinal chemistry letters, 2007-03, Vol.17 (5), p.1250-1253

2007

Volltextzugriff (PDF)

Synthesis and evaluation of unsaturated caprolactams as interleukin-1beta converting enzyme (ICE) inhibitors

Bioorganic & medicinal chemistry, 2007-02, Vol.15 (3), p.1311-1322

2007

Volltextzugriff (PDF)

Synthesis and evaluation of unsaturated caprolactams as interleukin-1β converting enzyme (ICE) inhibitors

Bioorganic & medicinal chemistry, 2007-02, Vol.15 (3), p.1311-1322

2007

Volltextzugriff (PDF)

Synthesis and evaluation of novel 8,5-fused bicyclic peptidomimetic compounds as interleukin-1beta converting enzyme (ICE) inhibitors

Bioorganic & medicinal chemistry, 2006-12, Vol.14 (23), p.7880

2006

Volltextzugriff (PDF)

The development of 2-benzimidazole substituted pyrimidine based inhibitors of lymphocyte specific kinase (Lck)

Bioorganic & medicinal chemistry letters, 2006-12, Vol.16 (23), p.5973-5977

2006

Volltextzugriff (PDF)

Synthesis and evaluation of novel 8,5-fused bicyclic peptidomimetic compounds as interleukin-1β converting enzyme (ICE) inhibitors

Bioorganic & medicinal chemistry, 2006-12, Vol.14 (23), p.7880-7892

2006

Volltextzugriff (PDF)

Design and synthesis of novel N-sulfonyl-2-indole carboxamides as potent PPAR-γ binding agents with potential application to the treatment of osteoporosis

Bioorganic & medicinal chemistry letters, 2006-11, Vol.16 (21), p.5659-5663

2006

Volltextzugriff (PDF)

Synthesis and evaluation of thiazepines as interleukin-1beta converting enzyme (ICE) inhibitors

Bioorganic & medicinal chemistry letters, 2006-09, Vol.16 (18), p.4728

2006

Volltextzugriff (PDF)

Synthesis and evaluation of thiazepines as interleukin-1β converting enzyme (ICE) inhibitors

Bioorganic & medicinal chemistry letters, 2006-09, Vol.16 (18), p.4728-4732

2006

Volltextzugriff (PDF)

Corrigendum to “Development of N-2,4-pyrimidine- N-phenyl- N′-phenyl ureas as inhibitors of tumor necrosis factor alpha (TNF-α) synthesis. Part 1” [Bioorg. Med. Chem. Lett. 16 (2006) 3510–3513]

Bioorganic & medicinal chemistry letters, 2006-09, Vol.16 (17), p.4700-4700

2006

Volltextzugriff (PDF)

The development of novel C-2, C-8, and N-9 trisubstituted purines as inhibitors of TNF-α production

Bioorganic & medicinal chemistry letters, 2006-08, Vol.16 (16), p.4360-4365

2006

Volltextzugriff (PDF)

The development of novel 1,2-dihydro-pyrimido[4,5- c]pyridazine based inhibitors of lymphocyte specific kinase (Lck)

Bioorganic & medicinal chemistry letters, 2006-08, Vol.16 (16), p.4257-4261

2006

Volltextzugriff (PDF)

Synthesis and evaluation of novel 1-(2-acylhydrazinocarbonyl)-cycloalkyl carboxamides as interleukin-1beta converting enzyme (ICE) inhibitors

Bioorganic & medicinal chemistry letters, 2006-08, Vol.16 (16), p.4233

2006

Volltextzugriff (PDF)

Synthesis and evaluation of novel 1-(2-acylhydrazinocarbonyl)-cycloalkyl carboxamides as interleukin-1β converting enzyme (ICE) inhibitors

Bioorganic & medicinal chemistry letters, 2006-08, Vol.16 (16), p.4233-4236

2006

Volltextzugriff (PDF)

Development of N-4,6-pyrimidine- N-alkyl- N′-phenyl ureas as orally active inhibitors of lymphocyte specific tyrosine kinase

Bioorganic & medicinal chemistry letters, 2006-07, Vol.16 (14), p.3646-3650

2006

Volltextzugriff (PDF)

Development of N-2,4-pyrimidine-N-phenyl-N′-alkyl ureas as orally active inhibitors of tumor necrosis factor alpha (TNF-α) synthesis. Part 2

Bioorganic & medicinal chemistry letters, 2006-07, Vol.16 (13), p.3514-3518

2006

Volltextzugriff (PDF)

Development of N-2,4-pyrimidine-N-phenyl-N′-phenyl ureas as inhibitors of tumor necrosis factor alpha (TNF-α) synthesis. Part 1

Bioorganic & medicinal chemistry letters, 2006-07, Vol.16 (13), p.3510-3513

2006

Volltextzugriff (PDF)

Synthesis and evaluation of novel 8,6-fused bicyclic peptidomimetic compounds as interleukin-1beta converting enzyme inhibitors

Bioorganic & medicinal chemistry letters, 2005-12, Vol.15 (24), p.5434-5438

2005

Volltextzugriff (PDF)

Synthesis and evaluation of novel 8,6-fused bicyclic peptidomimetic compounds as interleukin-1β converting enzyme inhibitors

Bioorganic & medicinal chemistry letters, 2005-12, Vol.15 (24), p.5434-5438

2005

Volltextzugriff (PDF)

1 – 25 von 38

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(38)
Mit Volltextzugriff
(38)

Publikationsform

Artikel
(38)

Sprache

Englisch
(38)
Japanisch
(3)

Erscheinungsjahr

n.n

Kollektion

3 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

2 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Letter to the editor

Letter to the editor

Threshold of Toxicological Concern: Extending the chemical space by inclusion of a highly curated dataset for organosilicon compounds

Framework for Identifying Chemicals with Structural Features Associated with the Potential to Act as Developmental or Reproductive Toxicants

Correlation of chemical structure with reproductive and developmental toxicity as it relates to the use of the threshold of toxicological concern

Carboxylic Acid-Terminated Hyperbranched Polybenzoxazole and Its Polyarm-Star Block Copolymers

Development of new pyrrolopyrimidine-based inhibitors of Janus kinase 3 (JAK3)

Synthesis and evaluation of unsaturated caprolactams as interleukin-1beta converting enzyme (ICE) inhibitors

Synthesis and evaluation of unsaturated caprolactams as interleukin-1β converting enzyme (ICE) inhibitors

Synthesis and evaluation of novel 8,5-fused bicyclic peptidomimetic compounds as interleukin-1beta converting enzyme (ICE) inhibitors

The development of 2-benzimidazole substituted pyrimidine based inhibitors of lymphocyte specific kinase (Lck)

Synthesis and evaluation of novel 8,5-fused bicyclic peptidomimetic compounds as interleukin-1β converting enzyme (ICE) inhibitors

Design and synthesis of novel N-sulfonyl-2-indole carboxamides as potent PPAR-γ binding agents with potential application to the treatment of osteoporosis

Synthesis and evaluation of thiazepines as interleukin-1beta converting enzyme (ICE) inhibitors

Synthesis and evaluation of thiazepines as interleukin-1β converting enzyme (ICE) inhibitors

Corrigendum to “Development of N-2,4-pyrimidine- N-phenyl- N′-phenyl ureas as inhibitors of tumor necrosis factor alpha (TNF-α) synthesis. Part 1” [Bioorg. Med. Chem. Lett. 16 (2006) 3510–3513]

The development of novel C-2, C-8, and N-9 trisubstituted purines as inhibitors of TNF-α production

The development of novel 1,2-dihydro-pyrimido[4,5- c]pyridazine based inhibitors of lymphocyte specific kinase (Lck)

Synthesis and evaluation of novel 1-(2-acylhydrazinocarbonyl)-cycloalkyl carboxamides as interleukin-1beta converting enzyme (ICE) inhibitors

Synthesis and evaluation of novel 1-(2-acylhydrazinocarbonyl)-cycloalkyl carboxamides as interleukin-1β converting enzyme (ICE) inhibitors

Development of N-4,6-pyrimidine- N-alkyl- N′-phenyl ureas as orally active inhibitors of lymphocyte specific tyrosine kinase

Development of N-2,4-pyrimidine-N-phenyl-N′-alkyl ureas as orally active inhibitors of tumor necrosis factor alpha (TNF-α) synthesis. Part 2

Development of N-2,4-pyrimidine-N-phenyl-N′-phenyl ureas as inhibitors of tumor necrosis factor alpha (TNF-α) synthesis. Part 1

Synthesis and evaluation of novel 8,6-fused bicyclic peptidomimetic compounds as interleukin-1beta converting enzyme inhibitors

Synthesis and evaluation of novel 8,6-fused bicyclic peptidomimetic compounds as interleukin-1β converting enzyme inhibitors

Suchergebnisse filtern